RE: Parntered with Phillips. Endorsed by largest US hospitals. Cash > Cap.26 Sep 2025 12:24
First Half Revenue: No new systems closed in the first half.
New Order: Significant new order from the NIH announced.
Consumable Growth: 36% increase in consumable usage in the first half of 2025 compared to 2024.
Revenue Guidance for 2025: Revised down to $2.5 million to $3.5 million from prior $5 million to $6 million.
Backlog: $1.2 million prior to the NIH announcement.
Cash Position: $7.3 million in cash as of June, with no debt.
Funding: Funded to operate through Q2 2026.
Quotes Increase: Over $21 million in quotes, a 650% increase year over year.